Maintenance Peginterferon Therapy and Other Factors Associated with Hepatocellular Carcinoma in Patients with Advanced Hepatitis C

BACKGROUND & AIMS: Interferon reportedly decreases the incidence of hepatocellular carcinoma (HCC) in patients with chronic hepatitis C. The Hepatitis C anti-viral long-term treatment against cirrhosis (HALT-C) trial showed that 4 years of maintenance therapy with peginterferon does not reduce l...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Lok, Anna S., Everhart, James E., Wright, Elizabeth C., Di Bisceglie, Adrian M., Kim, Hae-Young, Sterling, Richard K., Everson, Gregory T., Lindsay, Karen L., Lee, William M., Bonkovsky, Herbert L., Dienstag, Jules L., Ghany, Marc G., Morishima, Chihiro, Morgan, Timothy R.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2010
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3057272/
https://ncbi.nlm.nih.gov/pubmed/21129375
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.gastro.2010.11.050
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky